[{"Assets_0_Q3_USD":3198325000.0,"CIK":"875320","CommonStockSharesConverted_0_Q3_shares":252683346.0,"CommonStockSharesOutstanding_0_Q3_shares":252683346.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":-0.41,"EarningsPerShareBasic_3_Q3_USD":0.66,"EarningsPerShareDiluted_1_Q3_USD":-0.41,"EarningsPerShareDiluted_3_Q3_USD":0.64,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":617431000.0,"NetIncomeLossConverted_1_Q3_USD":-102952000.0,"NetIncomeLossConverted_3_Q3_USD":162800000.0,"OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","RevenuesConverted_1_Q3_USD":578165000.0,"RevenuesConverted_3_Q3_USD":1837018000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":1803244000.0,"StockholdersEquity_0_Q3_USD":1791077000.0,"Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":250268000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":252095000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":250268000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":247963000.0,"filed":"20171030","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2017.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20170930","qtrs":"0","uom":"USD"}]